Minerva Neurosciences hosts roluperidone update webcast; no specific details in 8-K

Minerva Neurosciences, Inc.

Company held an investor webcast on April 13, 2022, to discuss updates on roluperidone.
The 8-K filing includes only a cover page and dial-in information for the webcast.
No clinical data, regulatory milestones, or financial guidance were disclosed in the filing.
Investors must access the webcast replay or presentation to learn the actual update content.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.